Aquestive Therapeutics Stock (NASDAQ: AQST) stock price, news, charts, stock research, profile.
Open | $5.14 |
Close | - |
Volume / Avg. | 277.56K / 1.50M |
Day Range | $4.95 - $5.15 |
52 Wk Range | 1.25 - 6.23 |
Market Cap | $467.14M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 65 |
Short Interest | 14.21% |
Days to Cover | 10.08 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Aquestive Therapeutics (NASDAQ:AQST) through any online brokerage.
Other companies in Aquestive Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Zevra Therapeutics (NASDAQ:ZVRA), Theravance Biopharma (NASDAQ:TBPH), Third Harmonic Bio (NASDAQ:THRD) and GH Research (NASDAQ:GHRS).
Aquestive Therapeutics has a consensus price target of $8.39.
The stock price for Aquestive Therapeutics (NASDAQ: AQST) is $5.0846 last updated September 19, 2024 at 10:53 AM EDT.
There are no upcoming dividends for Aquestive Therapeutics.
Aquestive Therapeutics’s Q3 earnings are confirmed for Monday, November 4, 2024.
There is no upcoming split for Aquestive Therapeutics.
Aquestive Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.